SE413094B - Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur - Google Patents

Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur

Info

Publication number
SE413094B
SE413094B SE7501115A SE7501115A SE413094B SE 413094 B SE413094 B SE 413094B SE 7501115 A SE7501115 A SE 7501115A SE 7501115 A SE7501115 A SE 7501115A SE 413094 B SE413094 B SE 413094B
Authority
SE
Sweden
Prior art keywords
tyrosin
musculature
glossy
derivatives
preparation
Prior art date
Application number
SE7501115A
Other languages
English (en)
Swedish (sv)
Other versions
SE7501115L (sv
Inventor
F Makovec
L Rovati
P Senin
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Publication of SE7501115L publication Critical patent/SE7501115L/xx
Publication of SE413094B publication Critical patent/SE413094B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7501115A 1974-02-01 1975-01-31 Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur SE413094B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT67286/74A IT1062206B (it) 1974-02-01 1974-02-01 Derivati della tirosina attivi sulla muscolatura liscia

Publications (2)

Publication Number Publication Date
SE7501115L SE7501115L (sv) 1975-08-04
SE413094B true SE413094B (sv) 1980-04-14

Family

ID=11301149

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7501115A SE413094B (sv) 1974-02-01 1975-01-31 Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur
SE7501114A SE410850B (sv) 1974-02-01 1975-01-31 Forfarande for framstellning av d,l-tyrosinderivat med farmacentisk aktivitet pa glatt muskulatur

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7501114A SE410850B (sv) 1974-02-01 1975-01-31 Forfarande for framstellning av d,l-tyrosinderivat med farmacentisk aktivitet pa glatt muskulatur

Country Status (19)

Country Link
US (1) US4004008A (fr)
JP (2) JPS5417729B2 (fr)
AT (2) AT343632B (fr)
BE (1) BE824995A (fr)
CA (2) CA1047498A (fr)
CH (2) CH605657A5 (fr)
DE (1) DE2503992C2 (fr)
ES (1) ES434323A1 (fr)
FI (2) FI63744C (fr)
FR (1) FR2259592B1 (fr)
GB (1) GB1467927A (fr)
HK (1) HK38979A (fr)
HU (2) HU174825B (fr)
IN (1) IN139364B (fr)
IT (1) IT1062206B (fr)
NL (1) NL167683C (fr)
NO (2) NO144210C (fr)
SE (2) SE413094B (fr)
ZA (1) ZA75530B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5225243A (en) * 1975-08-20 1977-02-25 Toshiba Electric Equip Corp Distributing panel
US4579866A (en) * 1984-05-29 1986-04-01 Usv Pharmaceutical Corp. Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents
US5198458A (en) * 1986-02-04 1993-03-30 Suntory Limited Pyrrolidineamide derivatives of acylamino acid and pharmaceutical composition containing the same
CA1320734C (fr) * 1986-02-04 1993-07-27 Suntory Limited Derive pyrrolidineamide d'acide acylamine; composition pharmaceutique a base de ce derive
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them
US5258407A (en) * 1991-12-31 1993-11-02 Sterling Winthrop Inc. 3,4-disubstituted phenols-immunomodulating agents
US5206373A (en) * 1992-02-28 1993-04-27 Merck & Co., Inc. Process for preparing fibrinogen receptor antagonists
DE10204951A1 (de) * 2002-02-06 2003-08-14 Basf Ag Phenylalaninderivate als Herbizide
KR20060123344A (ko) * 2003-12-19 2006-12-01 바스프 악티엔게젤샤프트 벤조일-치환된 페닐알라닌아미드
BRPI0613423A2 (pt) * 2005-07-19 2012-12-11 Daiichi Sankyo Co Ltd composição farmacêutica, composto ou um seu sal farmaceuticamente aceitável, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
WO2011094890A1 (fr) * 2010-02-02 2011-08-11 Argusina Inc. Dérivés phénylalanines et leur utilisation comme modulateurs non peptidiques du récepteur de glp-1
EP2579888A2 (fr) 2010-06-09 2013-04-17 Receptos, Inc. Nouveaux stabilisants et modulateurs de récepteur glp-1
ES2634716T3 (es) 2011-05-31 2017-09-28 Celgene International Ii Sàrl Nuevos estabilizantes y moduladores del receptor GLP-1
EP2791112B1 (fr) 2011-12-12 2020-09-23 Celgene International II Sàrl Dérivés d'acide carboxylique comprenant quatre cycles agissant comme modulateurs du récepteur glp-1 pour la thérapie de maladies telles que le diabète
CN102659619A (zh) * 2012-04-18 2012-09-12 上海骏捷生化科技有限公司 一种合成酪氨酸衍生物的方法
CN103508921B (zh) * 2012-06-21 2015-09-30 贵州百灵企业集团制药股份有限公司 一种苯丙氨醇化合物的制备方法
CN103508920B (zh) * 2012-06-21 2016-03-02 贵州百灵企业集团制药股份有限公司 一种苯丙氨醇化合物的光学异构体的制备方法及其用途
EP3008056B8 (fr) 2013-06-11 2021-03-03 Receptos Llc Nouveaux modulateurs du récepteur glp-1
JP6556237B2 (ja) 2014-07-25 2019-08-07 セルジーン インターナショナル ツー エスエーアールエル 新規のｇｌｐ−１受容体モジュレーター
JP2017538711A (ja) 2014-12-10 2017-12-28 セルジーン インターナショナル ツー エスエーアールエル Ｇｌｐ−１レセプターモジュレーター
CN107417560B (zh) * 2017-03-30 2020-05-22 上海常丰生物医药科技有限公司 一种合成盐酸替罗酰胺的方法
CN110015978B (zh) * 2019-04-29 2021-03-19 康化（上海）新药研发有限公司 O-[2-[[叔丁氧羰基]氨基]乙基]-n-[芴甲氧羰基]-l-酪氨酸的合成方法
CN115850107A (zh) * 2022-11-30 2023-03-28 苏州诚和医药化学有限公司 一种工业化合成盐酸替罗酰胺的方法

Also Published As

Publication number Publication date
SE7501115L (sv) 1975-08-04
NL167683C (nl) 1982-01-18
FI63744C (fi) 1983-08-10
FR2259592A1 (fr) 1975-08-29
FI63744B (fi) 1983-04-29
NO144210B (no) 1981-04-06
FR2259592B1 (fr) 1978-07-21
JPS5417728B2 (fr) 1979-07-02
JPS50116441A (fr) 1975-09-11
JPS5417729B2 (fr) 1979-07-02
CH605658A5 (fr) 1978-10-13
HU175156B (hu) 1980-05-28
IT1062206B (it) 1983-09-20
NO144211C (no) 1981-07-15
CH605657A5 (fr) 1978-10-13
DE2503992A1 (de) 1975-08-14
CA1047498A (fr) 1979-01-30
GB1467927A (en) 1977-03-23
IN139364B (fr) 1976-06-12
HK38979A (en) 1979-06-22
FI750255A (fr) 1975-08-02
US4004008A (en) 1977-01-18
DE2503992C2 (de) 1982-01-21
CA1048503A (fr) 1979-02-13
FI750256A (fr) 1975-08-02
AU7775075A (en) 1976-08-05
NL7501193A (nl) 1975-08-05
NL167683B (nl) 1981-08-17
FI61479C (fi) 1982-08-10
NO750287L (fr) 1975-08-25
ES434323A1 (es) 1976-12-16
ATA74575A (de) 1977-07-15
ATA74675A (de) 1977-10-15
NO750288L (fr) 1975-08-25
SE410850B (sv) 1979-11-12
NO144210C (no) 1981-07-15
FI61479B (fi) 1982-04-30
SE7501114L (sv) 1975-08-04
BE824995A (fr) 1975-05-15
JPS50116442A (fr) 1975-09-11
NO144211B (no) 1981-04-06
ZA75530B (en) 1976-01-28
AT342026B (de) 1978-03-10
HU174825B (hu) 1980-03-28
AT343632B (de) 1978-06-12

Similar Documents

Publication Publication Date Title
SE413094B (sv) Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur
NO143218C (no) Analogifremgangsmaate til fremstilling av nonapeptidamider med lh-rh aktivitet
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO140859C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive n-(metoksymetyl-furylmetyl)-6,7-benzomorfaner og -morfinaner
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
SE423544B (sv) Analogiforfarande for framstellning av imidazolderivat med antifungisk aktivitet
SE420598B (sv) Analogiforfarande for framstellning av naftalenderivat
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE7507564L (sv) Aluminiumhydridoligomerderivat samt forfarande for framstellning av desamma.
NO142524C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
NO149775C (no) Analogifremgangsmaate for fremstilling av fenyl-pyridylamin-derivater med antidepressiv virkning
NO142403C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner.
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
NO144488C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat